Cetera Investment Advisers’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
55,854
+352
| +0.6% | +$27.5K | 0.01% | 1277 |
|
|
2025
Q1 | $4.02M | Buy |
+55,502
| New | +$4.02M | 0.01% | 1254 |
|
|
2024
Q3 | – | Sell |
-140,686
| Closed | -$13M | – | 3753 |
|
|
2024
Q2 | $13M | Sell |
140,686
-5,154
| -4% | -$476K | 0.03% | 563 |
|
|
2024
Q1 | $13.9M | Buy |
145,840
+98,038
| +205% | +$9.37M | 0.03% | 525 |
|
|
2023
Q4 | $3.64M | Sell |
47,802
-2,022
| -4% | -$154K | 0.03% | 557 |
|
|
2023
Q3 | $3.45M | Buy |
49,824
+1,238
| +3% | +$85.8K | 0.03% | 543 |
|
|
2023
Q2 | $4.58M | Buy |
48,586
+2,439
| +5% | +$230K | 0.04% | 434 |
|
|
2023
Q1 | $3.82M | Sell |
46,147
-1,738
| -4% | -$144K | 0.03% | 482 |
|
|
2022
Q4 | $3.57M | Sell |
47,885
-14,217
| -23% | -$1.06M | 0.03% | 488 |
|
|
2022
Q3 | $5K | Buy |
62,102
+27,941
| +82% | +$2.25K | ﹤0.01% | 1672 |
|
|
2022
Q2 | $3.25M | Sell |
34,161
-499
| -1% | -$47.4K | 0.05% | 364 |
|
|
2022
Q1 | $4.08M | Buy |
34,660
+621
| +2% | +$73.1K | 0.06% | 331 |
|
|
2021
Q4 | $4.41M | Buy |
34,039
+1,576
| +5% | +$204K | 0.06% | 306 |
|
|
2021
Q3 | $3.68M | Sell |
32,463
-112
| -0.3% | -$12.7K | 0.06% | 342 |
|
|
2021
Q2 | $3.37M | Buy |
32,575
+17,492
| +116% | +$1.81M | 0.05% | 368 |
|
|
2021
Q1 | $1.26M | Sell |
15,083
-12,559
| -45% | -$1.05M | 0.02% | 573 |
|
|
2020
Q4 | $2.52M | Buy |
27,642
+23,844
| +628% | +$2.18M | 0.05% | 373 |
|
|
2020
Q3 | $303K | Sell |
3,798
-2,474
| -39% | -$197K | 0.02% | 496 |
|
|
2020
Q2 | $433K | Buy |
6,272
+119
| +2% | +$8.22K | 0.04% | 385 |
|
|
2020
Q1 | $387K | Sell |
6,153
-39
| -0.6% | -$2.45K | 0.05% | 349 |
|
|
2019
Q4 | $481K | Buy |
6,192
+1,458
| +31% | +$113K | 0.05% | 346 |
|
|
2019
Q3 | $346K | Buy |
+4,734
| New | +$346K | 0.04% | 375 |
|